Concepedia

Shawn F. Johnson

SF

10

Publications

2K

Citations

10

H-Index

2012

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Fox Chase Cancer Center

University of Washington

Shawn F. Johnson is an author at Harvard University specializing in medicine, cell biology, and oncology.

ORCID

Top concepts

Publications per year

2012–2022

10

Publications

10

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera et al. · Nature · 2017 · 540 citations · Full text

, , +9

Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer

Jian Hu, Soyoon Hwang, Marc Liesa et al. · Cell · 2012 · 286 citations · Full text

, , +7

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 279 citations · Full text

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Yifan Wang, Andrea J. Bernhardy, Cristina Cruz et al. · Cancer Research · 2016 · 267 citations · Full text

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Neil Johnson, Shawn F. Johnson, Wei Yao et al. · Proceedings of the National Academy of Sciences · 2013 · 261 citations · Full text

Rows per page

1–5 of 10